S
Samira Matin
Researcher at Tabriz University of Medical Sciences
Publications - 6
Citations - 539
Samira Matin is an academic researcher from Tabriz University of Medical Sciences. The author has contributed to research in topics: Randomized controlled trial & Internal medicine. The author has an hindex of 3, co-authored 3 publications receiving 168 citations.
Papers
More filters
Journal ArticleDOI
Effect of Intermediate-Dose vs Standard-Dose Prophylactic Anticoagulation on Thrombotic Events, Extracorporeal Membrane Oxygenation Treatment, or Mortality Among Patients With COVID-19 Admitted to the Intensive Care Unit: The INSPIRATION Randomized Clinical Trial.
Inspiration Investigators,Parham Sadeghipour,Azita Hajhossein Talasaz,Farid Rashidi,Babak Sharif-Kashani,Mohammad Taghi Beigmohammadi,Mohsen Farrokhpour,Seyed Hashem Sezavar,Pooya Payandemehr,Ali Dabbagh,Keivan Gohari Moghadam,Sepehr Jamalkhani,Hossein Khalili,Mahdi Yadollahzadeh,Taghi Riahi,Parisa Rezaeifar,Ouria Tahamtan,Samira Matin,Atefeh Abedini,Somayeh Lookzadeh,Hamid Reza Rahmani,Elnaz Zoghi,Keyhan Mohammadi,Pardis Sadeghipour,Homa Abri,Sanaz Hariri Tabrizi,Seyed Masoud Mousavian,Shaghayegh Shahmirzaei,Hooman Bakhshandeh,Ahmad Amin,Farnaz Rafiee,Elahe Baghizadeh,Bahram Mohebbi,Seyed Ehsan Parhizgar,Rasoul Aliannejad,Vahid Eslami,Alireza Kashefizadeh,Hessam Kakavand,Seyed Hossein Hosseini,Shadi Shafaghi,Samrand Fattah Ghazi,Atabak Najafi,David Jiménez,Aakriti Gupta,Aakriti Gupta,Mahesh V. Madhavan,Sanjum S. Sethi,Sahil A. Parikh,Manuel Monreal,Naser Hadavand,Alireza Hajighasemi,Majid Maleki,Saeed Sadeghian,Gregory Piazza,Ajay J. Kirtane,Benjamin W. Van Tassell,Paul P. Dobesh,Gregg W. Stone,Gregory Y.H. Lip,Gregory Y.H. Lip,Harlan M. Krumholz,Samuel Z. Goldhaber,Behnood Bikdeli,Behnood Bikdeli +63 more
TL;DR: In this paper, the authors evaluated the effects of intermediate-dose vs standard-dose prophylactic anticoagulation among patients with COVID-19 admitted to the intensive care unit (ICU).
Journal ArticleDOI
Intermediate versus standard-dose prophylactic anticoagulation and statin therapy versus placebo in critically-ill patients with COVID-19: Rationale and design of the INSPIRATION/INSPIRATION-S studies.
Behnood Bikdeli,Azita Hajhossein Talasaz,Farid Rashidi,Babak Sharif-Kashani,Mohsen Farrokhpour,Hooman Bakhshandeh,S H Sezavar,Ali Dabbagh,Mohammad Taghi Beigmohammadi,Pooya Payandemehr,Mahdi Yadollahzadeh,Taghi Riahi,Hossein Khalili,Sepehr Jamalkhani,Parisa Rezaeifar,Atefeh Abedini,Somayeh Lookzadeh,Shaghayegh Shahmirzaei,Ouria Tahamtan,Samira Matin,Ahmad Amin,Seyed Ehsan Parhizgar,David Jiménez,Aakriti Gupta,Mahesh V. Madhavan,Sahil A. Parikh,Manuel Monreal,Naser Hadavand,Alireza Hajighasemi,Majid Maleki,Saeed Sadeghian,Bahram Mohebbi,Gregory Piazza,Ajay J. Kirtane,Gregory Y.H. Lip,Harlan M. Krumholz,Samuel Z. Goldhaber,Parham Sadeghipour +37 more
TL;DR: INSPIRATION and INSPIRATON-S studies will help address clinically-relevant questions for antithrombotic therapy and thromboinflammatory therapy in critically-ill patients with COVID-19 and test two independent hypotheses within a randomized control trial with 2 × 2 factorial design.
Journal ArticleDOI
Intermediate-Dose versus Standard-Dose Prophylactic Anticoagulation in Patients with COVID-19 Admitted to the Intensive Care Unit: 90-Day Results from the INSPIRATION Randomized Trial.
Behnood Bikdeli,Behnood Bikdeli,Azita Hajhossein Talasaz,Farid Rashidi,Hooman Bakhshandeh,Farnaz Rafiee,Parisa Rezaeifar,Elahe Baghizadeh,Samira Matin,Sepehr Jamalkhani,Ouria Tahamtan,Babak Sharif-Kashani,Mohammad Taghi Beigmohammadi,Mohsen Farrokhpour,Seyed Hashem Sezavar,Pooya Payandemehr,Ali Dabbagh,Keivan Gohari Moghadam,Hossein Khalili,Mahdi Yadollahzadeh,Taghi Riahi,Atefeh Abedini,Somayeh Lookzadeh,Hamid Reza Rahmani,Elnaz Zoghi,Keyhan Mohammadi,Pardis Sadeghipour,Homa Abri,Sanaz Hariri Tabrizi,Seyed Masoud Mousavian,Shaghayegh Shahmirzaei,Ahmad Amin,Bahram Mohebbi,Seyed Ehsan Parhizgar,Rasoul Aliannejad,Vahid Eslami,Alireza Kashefizadeh,Paul P. Dobesh,Hessam Kakavand,Seyed Hossein Hosseini,Shadi Shafaghi,Samrand Fattah Ghazi,Atabak Najafi,David Jiménez,Aakriti Gupta,Aakriti Gupta,Mahesh V. Madhavan,Sanjum S. Sethi,Sahil A. Parikh,Manuel Monreal,Manuel Monreal,Naser Hadavand,Alireza Hajighasemi,Majid Maleki,Saeed Sadeghian,Gregory Piazza,Ajay J. Kirtane,Benjamin W. Van Tassell,Gregg W. Stone,Gregory Y.H. Lip,Gregory Y.H. Lip,Harlan M. Krumholz,Samuel Z. Goldhaber,Parham Sadeghipour,Parham Sadeghipour +64 more
TL;DR: In this article, the authors report the final (90-day) results of the Intermediate versus Standard-dose Prophylactic anticoagulation In cRitically-ill pATIents with COVID-19: An opeN label randomized controlled trial (INSPIRATION) study.
Journal ArticleDOI
Hematological Parameters as Diagnostic Factors: Correlation with Severity of COVID-19
Somaieh Matin,Elham Safarzadeh,Nima Rezaei,M. Negaresh,Hossein Salehzadeh,Samira Matin,Amir Hossein Sharifiazar,Malek Abazari,Masoomeh Dadkhah +8 more
TL;DR: Elevated NLR can be assumed as an independent biomarker, which could provide a crucial indicator in the monitoring patients with COVID-19 on admission, and increased NLR was correlated with the severity of CO VID-19.
Journal ArticleDOI
Atorvastatin versus Placebo in ICU Patients with COVID-19: Ninety-day Results of the INSPIRATION-S Trial
Azita Hajhossein Talasaz,Parham Sadeghipour,Hooman Bakhshandeh,Babak Sharif-Kashani,Farid Rashidi,Mohammad Taghi Beigmohammadi,Keivan Gohari Moghadam,Somayeh Rezaian,Ali Dabbagh,S H Sezavar,Mohsen Farrokhpour,Atefeh Abedini,Rasoul Aliannejad,Taghi Riahi,Mahdi Yadollahzadeh,Somayeh Lookzadeh,Parisa Rezaeifar,Samira Matin,Ooria Tahamtan,Keyhan Mohammadi,Elnaz Zoghi,Hamid Rahmani,Seyed Hossein Hosseini,SeyedAmir Mousavian,Homa Abri,Pardis Sadeghipour,Elaheh Baghizadeh,Farnaz Rafiee,Sepehr Jamalkhani,Ahmad Amin,Bahram Mohebbi,Seyed Ehsan Parhizgar,Mahshid Soleimanzadeh,Maryam Aghakouchakzadeh,Vahid Eslami,Pooya Payandemehr,Hossein Khalili,Hamed Talakoob,Taranom Tojari,Shadi Shafaghi,Sanaz Alizadeh Tabrizi,Hessam Kakavand,Alireza Kashefizadeh,Atabak Najafi,David Jiménez,Aakriti Gupta,Mahesh V. Madhavan,Sanjum S. Sethi,Sahil A. Parikh,Manuel Monreal,Naser Hadavand,Alireza Hajighasemi,Khalil Ansarin,Majid Maleki,Saeed Sadeghian,Stefano Barco,Bob Siegerink,Erica S. Spatz,Gregory Piazza,Ajay J. Kirtane,Benjamin W. Van Tassell,Gregory Y.H. Lip,E. Klok,Samuel Z. Goldhaber,Gregg W. Stone,Harlan M. Krumholz,Behnood Bikdeli +66 more
TL;DR: In this article, the effects of atorvastatin 20 mg daily versus placebo on 90-day clinical and functional outcomes from INSPIRATION-S, a double-blind multicenter randomized trial of adult ICU patients with COVID-19 were reported.